Published in Cell Mol Life Sci on February 01, 2007
Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev (2012) 3.44
The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res (2009) 3.42
In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small (2008) 2.09
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med (2013) 1.59
Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol (2009) 1.54
Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small (2009) 1.49
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci (2010) 1.41
ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res (2009) 1.40
A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One (2010) 1.34
Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3. Mol Cancer Ther (2010) 1.33
Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. Cancer Res (2009) 1.30
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clin Invest (2008) 1.29
Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics (2008) 1.28
Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell (2008) 1.27
Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials (2011) 1.27
Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. Cancer Res (2011) 1.25
Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro. Cell Cycle (2012) 1.23
Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther (2011) 1.22
Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling. Cancer Res (2012) 1.17
Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci U S A (2009) 1.17
A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. Neoplasia (2010) 1.16
MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci (2014) 1.16
Hydrodynamic cellular volume changes enable glioma cell invasion. J Neurosci (2011) 1.16
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer (2010) 1.15
Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res (2010) 1.14
Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol (2010) 1.13
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion. Int J Cancer (2010) 1.12
Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Mol Cancer Res (2012) 1.08
Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression. Front Oncol (2013) 1.05
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro Oncol (2013) 1.04
Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail. Cancer Res (2011) 1.04
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol (2008) 1.03
Galectins and gliomas. Brain Pathol (2009) 1.01
Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma. Neuro Oncol (2010) 1.00
Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion. Cancer Res (2015) 0.98
αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell (2013) 0.97
Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer (2012) 0.96
Aberrant signaling pathways in glioma. Cancers (Basel) (2011) 0.96
Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies. Expert Rev Neurother (2009) 0.95
αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol (2010) 0.94
Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells. Mol Cells (2010) 0.94
MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One (2013) 0.93
Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev (2011) 0.93
Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells. PLoS One (2013) 0.93
Role of Eph/ephrin tyrosine kinase in malignant glioma. Neuro Oncol (2011) 0.90
Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia (2009) 0.90
Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion. Br J Cancer (2013) 0.89
Mesenchymal migration as a therapeutic target in glioblastoma. J Oncol (2010) 0.89
A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS One (2014) 0.89
MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol (2013) 0.88
Coordination of glioblastoma cell motility by PKCι. Mol Cancer (2010) 0.88
The transglutaminase 2 gene is aberrantly hypermethylated in glioma. J Neurooncol (2010) 0.87
The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. J Neurooncol (2010) 0.87
Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251. J Exp Clin Cancer Res (2011) 0.87
Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme. Biomed Res Int (2014) 0.86
Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells. BMC Cancer (2012) 0.86
Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP). J Biol Chem (2012) 0.85
Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer (2010) 0.85
Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. J Cell Sci (2013) 0.85
Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges. Onco Targets Ther (2013) 0.84
Superoxide mediates direct current electric field-induced directional migration of glioma cells through the activation of AKT and ERK. PLoS One (2013) 0.83
Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas. Int J Cancer (2011) 0.82
Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration. J Cell Biochem (2011) 0.82
Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo. Neuro Oncol (2012) 0.82
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells. Oncotarget (2015) 0.82
Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death. Mol Cell Biol (2014) 0.81
Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels. ACS Appl Mater Interfaces (2013) 0.81
Extracellular Matrix Properties Regulate the Migratory Response of Glioblastoma Stem Cells in Three-Dimensional Culture. Tissue Eng Part A (2015) 0.81
Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival. Neuro Oncol (2013) 0.80
The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. Exp Cell Res (2013) 0.80
Expanding the utility of beta-galactosidase complementation: piece by piece. Mol Pharm (2010) 0.80
A conspiracy of glioma and endothelial cells to invade the normal brain. Oncotarget (2011) 0.79
Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells. Biochem Pharmacol (2015) 0.79
Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin. Mol Cells (2015) 0.79
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme. Oncotarget (2015) 0.79
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis. PLoS One (2013) 0.79
Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway. J Mol Histol (2013) 0.79
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics. Oncogene (2015) 0.79
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation. Carcinogenesis (2013) 0.78
A coculture assay to visualize and monitor interactions between migrating glioma cells and nerve fibers. Nat Protoc (2009) 0.78
Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells. Tissue Eng Part B Rev (2013) 0.77
EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins. J Neurooncol (2009) 0.77
Multiphoton imaging of actin filament formation and mitochondrial energetics of human ACBT gliomas. Photochem Photobiol (2011) 0.77
Proton beam irradiation stimulates migration and invasion of human U87 malignant glioma cells. J Radiat Res (2013) 0.77
Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells. Neuro Oncol (2015) 0.77
Anti-tumoral effects of miR-3189-3p in glioblastoma. J Biol Chem (2015) 0.76
Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1. Oncogene (2015) 0.76
Syntenin is expressed in human gliomas and may correlate with tumor migration. Arch Med Sci (2015) 0.75
PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression. Front Pharmacol (2016) 0.75
Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration. Front Cell Neurosci (2015) 0.75
RUNX3 is down-regulated in glioma by Myc-regulated miR-4295. J Cell Mol Med (2016) 0.75
Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression. Mol Med Rep (2015) 0.75
Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas. Int J Clin Exp Pathol (2015) 0.75
The relationship between the expression of tumor matrix-metalloproteinase and the characteristics of magnetic resonance imaging of human gliomas. J Biomed Res (2010) 0.75
Deleterious c-Cbl Exon Skipping Contributes to Human Glioma. Neoplasia (2015) 0.75
Reduction in gap junction intercellular communication promotes glioma migration. Oncotarget (2015) 0.75
RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics. Oncotarget (2016) 0.75
Expression and Distribution Characteristics of Human Ortholog of Mammalian Enabled (hMena) in Glioma. Chin J Cancer Res (2011) 0.75
Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy. Mol Biol Cell (2015) 0.75
Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells. Oncol Lett (2016) 0.75
Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol (2003) 5.28
Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science (1986) 4.64
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
Dichotomy of astrocytoma migration and proliferation. Int J Cancer (1996) 2.26
Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun (1991) 2.10
Subtractive cDNA cloning using oligo(dT)30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res (1991) 2.08
Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol (1994) 2.05
Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif (2001) 1.86
Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology (1993) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Transcription of a recombinant influenza virus RNA in cells that can express the influenza virus RNA polymerase and nucleoprotein genes. J Gen Virol (1992) 1.75
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol (2001) 1.72
Complications of laparoscopic procedures after concentrated training in urological laparoscopy. J Urol (2001) 1.71
Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology (1987) 1.68
Epidemiology of influenza C virus in man: multiple evolutionary lineages and low rate of change. Virology (1986) 1.67
Regulation of influenza virus RNA polymerase activity by cellular and viral factors. Nucleic Acids Res (1994) 1.62
Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. J Virol (1985) 1.55
Regulation of Rad51 function by c-Abl in response to DNA damage. J Biol Chem (1998) 1.53
Noncumulative sequence changes in the hemagglutinin genes of influenza C virus isolates. Virology (1985) 1.48
Role for p300 in stabilization of p53 in the response to DNA damage. J Biol Chem (1999) 1.43
The environmental Web: a national profile of the state infrastructure for environmental health and protection. J Public Health Manag Pract (1997) 1.38
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin Cancer Res (1997) 1.36
Determinants of human astrocytoma migration. Cancer Res (1994) 1.34
Complete nucleotide sequence of the influenza C/California/78 virus nucleoprotein gene. Virus Res (1984) 1.32
The RNA polymerase PB2 subunit is not required for replication of the influenza virus genome but is involved in capped mRNA synthesis. J Virol (1995) 1.29
Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res (2001) 1.28
Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins. J Virol (1984) 1.28
Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene (1998) 1.26
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol (1988) 1.23
Migration of human glioma cells on myelin. Neurosurgery (1996) 1.20
Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res (2001) 1.13
Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. Cancer Res (1998) 1.12
Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage. Mol Cell Biol (1999) 1.12
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer (1989) 1.07
Substrates for astrocytoma invasion. Neurosurgery (1995) 1.04
Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells. Oncogene (1993) 1.02
A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development. Histol Histopathol (2007) 1.01
Role for E2F in DNA damage-induced entry of cells into S phase. Cancer Res (1997) 1.00
Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res (1990) 1.00
Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep (2001) 0.99
Function for p300 and not CBP in the apoptotic response to DNA damage. Oncogene (1999) 0.98
E1A-responsive elements for repression of rat fibronectin gene transcription. Mol Cell Biol (1992) 0.98
Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol (1998) 0.93
Growth complementation of influenza virus temperature-sensitive mutants in mouse cells which express the RNA polymerase and nucleoprotein genes. J Biochem (1991) 0.93
An in vivo study of the replication origin in the influenza virus complementary RNA. J Biochem (1993) 0.90
Induction of E1A-responsive negative factors for transcription of the fibronectin gene in adenovirus E1-transformed rat cells. J Virol (1992) 0.89
Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res Mol Brain Res (1991) 0.88
Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci (1996) 0.88
Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine. Oncogene (1997) 0.87
Influenza C virus RNA 7 codes for a nonstructural protein. J Virol (1985) 0.87
Molecular dissection of influenza virus RNA polymerase: PB1 subunit alone is able to catalyze RNA synthesis. Virus Genes (1996) 0.86
The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int J Cancer (1988) 0.86
Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro Oncol (1999) 0.86
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res (2001) 0.85
Gap junction intercellular communication in gliomas is inversely related to cell motility. Int J Dev Neurosci (1999) 0.85
Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product. Exp Cell Res (1993) 0.84
The influenza C virus NS gene: evidence for a spliced mRNA and a second NS gene product (NS2 protein). Virus Res (1986) 0.84
An immunohistochemical analysis of the temporal and spatial expression of growth factors FGF 1, 2 and 18, IGF 1 and 2, and TGFbeta1 during distraction osteogenesis. Histol Histopathol (2007) 0.83
Changes of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA. Mol Cell Biochem (1994) 0.83
A transient decrease in N-myc expression and its biological role during differentiation of human embryonal carcinoma cells. Differentiation (1991) 0.83
Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display. Cancer (2000) 0.83
A normal human brain cell aggregate model for neurobiological studies. J Neurosci Res (1989) 0.83
Expression of various viral and cellular enhancer-promoters during differentiation of human embryonal carcinoma cells. Differentiation (1990) 0.83
Two-step transformation of rat 3Y1 cells by the adenovirus E1A and E1B genes. Virus Genes (1990) 0.82
Bioequivalence: individual and population compartmental modeling compared to the noncompartmental approach. Pharm Res (1996) 0.82
Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate. Urology (1996) 0.82
Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Biochem Biophys Res Commun (1997) 0.81
Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Cancer Res (1991) 0.81
Mechanism of induction of cellular DNA synthesis by the adenovirus E1A 12S cDNA product. Exp Cell Res (1992) 0.81
Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J Neurooncol (1996) 0.81
In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. Cancer Res (1988) 0.80
Interaction of nuclear factors with the regulatory region of the N-myc gene during differentiation of human embryonal carcinoma cells. Gene (1991) 0.80
Development of a Dietary Exposure Potential Model for evaluating dietary exposure to chemical residues in food. J Expo Anal Environ Epidemiol (1997) 0.80
Inhibition of phosphatidylinositol 3-kinase by c-Abl in the genotoxic stress response. J Biol Chem (1997) 0.80
Inhibitory effect of modified 5'-capped short RNA fragments on influenza virus RNA polymerase gene expression. Antivir Chem Chemother (2001) 0.80
Changes of cell cycle-regulating genes in interferon-treated Daudi cells. Mol Cell Biochem (1994) 0.80
Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. J Neurooncol (1991) 0.80
Effect of mercurials on lymphocyte functions in vitro. Toxicology (1985) 0.80
Characterization of a canine glioma cell line as related to established experimental brain tumor models. J Neuropathol Exp Neurol (2000) 0.79
Quantitative analysis of prostaglandins in cell culture medium by high-resolution gas chromatography with electron-capture detection. J Chromatogr (1984) 0.79
Migration arrest in glioma cells is dependent on the alphav integrin subunit. Glia (1998) 0.79
Neoplastic cell inhibition with new ether lipid analogs. Lipids (1987) 0.78
Tumour necrosis factor-alpha enhances cAMP-induced programmed cell death in mouse thymocytes. Cytokine (1993) 0.78
In vitro growth characteristics and chemosensitivities of endometrial cancer using a soft agar clonogenic assay. Obstet Gynecol (1987) 0.78
Change in permeability of liposomes caused by methylmercury and inorganic mercury. Chem Biol Interact (1978) 0.78
Comparison of automated and conventional keratometers. Am J Ophthalmol (1984) 0.78
A new model for evaluating corneal wound strength in the rabbit. Invest Ophthalmol Vis Sci (1992) 0.78
Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay. Cancer Res (1986) 0.78
Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma. Arthritis Rheum (1993) 0.77
Stimulation of DNA synthesis and pyrimidine deoxyribonucleoside transport systems in mouse glioma and mouse neuroblastoma cells by inorganic mercury. Toxicol Appl Pharmacol (1980) 0.77
Allergenic and immunogenic components of house dust mite, Dermatophagoides farinae. Ann Allergy (1986) 0.77
[Disseminated MALT lymphoma associated with macroglobulinemia]. Rinsho Ketsueki (2000) 0.77
Alterations in the inotropic responses to forskolin and Ca2+ and reduced gene expressions of Ca2+-signaling proteins induced by chronic volume overload in rabbits. Jpn Circ J (2000) 0.77